Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (51-60 of 211) with videos related to

Pageof 22
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 26, 2019
Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomesRémi Grange, Farouk Tradi, Jean Izaaryene, et al.
Cancers|August 12, 2023
Retrospective Evaluation of a Single Surgeon's Learning Curve of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion via Ileal ConduitChristof Achermann, Andreas Sauer, Marco Cattaneo, et al.
The Journal of Urology|May 15, 2007
Ejaculatory disorders may affect screening for prostate cancerJochen Walz, Paul Perrotte, Andrea Gallina, et al.
BJU International|October 19, 2007
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of menJochen Walz, Paul Perrotte, Georg Hutterer, et al.
European Urology Open Science|September 17, 2025
Development of the CAMUS Intra- and Postoperative Risk and Difficulty Estimation Indices Risk Prediction Tool for Estimating Peri- and Postoperative Outcomes, Including Surgical Difficulty, in Major Urological Surgery-A Protocol for a Delphi StudyChristopher Soliman, Patrick Y Wuethrich, Jochen Walz, et al.
The Journal of Urology|February 26, 2008
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomyShahrokh F Shariat, Jochen Walz, Claus G Roehrborn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
Factors predicting biochemical response and survival benefits following radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a reviewReyhaneh Manafi-Farid, Sara Harsini, Bahare Saidi, et al.
World Journal of Urology|June 27, 2020
Metastatic hormone sensitive prostate cancer: local treatment strategiesJochen Walz, Geraldine Pignot, Sami Fakhfakh, et al.
European Urology|May 5, 2018
Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our PatientsRafael Sanchez-Salas, Jean de la Rosette, Thomas J Polascik, et al.
European Urology|November 26, 2008
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomyJochen Walz, Felix K H Chun, Eric A Klein, et al.
Pageof 22

Showing results (51-60 of 211) with videos related to

Sort By:
Pageof 22
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 26, 2019
Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomesRémi Grange, Farouk Tradi, Jean Izaaryene, et al.
Cancers|August 12, 2023
Retrospective Evaluation of a Single Surgeon's Learning Curve of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion via Ileal ConduitChristof Achermann, Andreas Sauer, Marco Cattaneo, et al.
The Journal of Urology|May 15, 2007
Ejaculatory disorders may affect screening for prostate cancerJochen Walz, Paul Perrotte, Andrea Gallina, et al.
BJU International|October 19, 2007
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of menJochen Walz, Paul Perrotte, Georg Hutterer, et al.
European Urology Open Science|September 17, 2025
Development of the CAMUS Intra- and Postoperative Risk and Difficulty Estimation Indices Risk Prediction Tool for Estimating Peri- and Postoperative Outcomes, Including Surgical Difficulty, in Major Urological Surgery-A Protocol for a Delphi StudyChristopher Soliman, Patrick Y Wuethrich, Jochen Walz, et al.
The Journal of Urology|February 26, 2008
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomyShahrokh F Shariat, Jochen Walz, Claus G Roehrborn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
Factors predicting biochemical response and survival benefits following radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a reviewReyhaneh Manafi-Farid, Sara Harsini, Bahare Saidi, et al.
World Journal of Urology|June 27, 2020
Metastatic hormone sensitive prostate cancer: local treatment strategiesJochen Walz, Geraldine Pignot, Sami Fakhfakh, et al.
European Urology|May 5, 2018
Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our PatientsRafael Sanchez-Salas, Jean de la Rosette, Thomas J Polascik, et al.
European Urology|November 26, 2008
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomyJochen Walz, Felix K H Chun, Eric A Klein, et al.
Pageof 22